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Florida, USAERCP is the standard procedure for endoscopic biliary
therapy. The endoscopic approach to the ampulla followed
by selective deep biliary cannulation is the ﬁrst step before
further therapy. Difﬁcult biliary access can occur during
endoscope intubation or when attempting selective biliary
cannulation in normal or surgically altered anatomy. Difﬁ-
cult cannulation increases the risk of post-ERCP adverse
events, particularly post-ERCP pancreatitis (PEP) and perfo-
ration. In normal anatomy, about 11% of therapeutic
ERCPs may be considered difﬁcult biliary cannulation.1
Biliary access in patients with surgically altered anatomy,
such as Billroth II or Roux-en-Y anastomosis, is considered
difﬁcult because special instruments and maneuvers are
often needed.
Various methods are used to overcome difﬁcult biliary
access, including advanced ERCP-based techniques using
precut papillotomy or double guidewires (DGWs), special-
ized instruments like echoendoscopes or device-assisted
enteroscopy, or percutaneous approach. These techniques
and procedures are more complex and carry signiﬁcant
risks, requiring speciﬁc training. This consensus aims to
develop an evidence-based framework for biliary endo-
scopists to tackle difﬁcult biliary access.ns: CI, confidence interval; DGW, double guidewire; EUS-BD,
biliary drainage; EUS-HGS, EUS-guided hepaticogastrostomy;
-knife fistulotomy; NKP, needle-knife papillotomy; OR, odds
post-ERCP pancreatitis; PTBD, percutaneous transhepatic
inage; RCT, randomized controlled trial; SEMS, self-
metal stent; TPS, transpancreatic septotomy.
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Based on literature search through MEDLINE, Cochrane
Library, and Embase, a planning panel (W.C.L., P.A., H.I.,
R.R., H.P.W.) drafted statements on 3 areas: difﬁcult biliary
access in normal anatomy, difﬁcult biliary access in surgi-
cally altered anatomy, and EUS- or percutaneous-guided
biliary access. The ﬁrst draft was distributed electronically
to the panel members who evaluated each statement
(Table 1). A face-to-face meeting was conducted in July
2015 in Taipei, Taiwan, to review and discuss the evidence
and revise the statements. The members then indepen-
dently voted on each statement via an electronic system.
Consensus was considered to be achieved when 80% or
more of voting members indicated “accept completely”
or “accept with some reservation.” A statement was
rejected when 80% or more of voting members “reject
completely” or “reject with some reservation.” Finally, 13
statements achieved consensus. The level of evidence
and grade of recommendation were rated with the evi-
dence leveling system2 (Table 1).CONSENSUS STATEMENTS
1. Difﬁcult biliary access is deﬁned as the inability to
achieve selective biliary cannulation by standard ERCP
techniques within 10 minutes or up to 5 cannulation
attempts or failure of access to the major papilla.
Evidence level: II-A
Recommendation grade: B
Voting on recommendation: A, 56%; B, 44%; C, 0%;
D, 0%; E, 0%
Guidewire-assisted cannulation is considered the stan-
dard technique for biliary access.3,4 Increased cannulation
time, number of cannulation attempts, and number of
pancreatic duct injections/cannulations have been associ-
ated with increased risk of PEP.5-7 Therefore, an upper limit
of cannulation time and number of attempts should be setVolume 85, No. 2 : 2017 GASTROINTESTINAL ENDOSCOPY 295
TABLE 1. Classification of evidence levels, recommendation grades,
and voting on recommendation
Level/grade Description
Evidence level
I-A Evidence from meta-analysis of RCTs
I-B Evidence from at least 1 RCT
II-A Evidence from at least 1 controlled study
without randomization
II-B Evidence from at least 1 other type of
quasi-experimental study
III Evidence from nonexperimental
descriptive studies, such as comparative
studies, correlation studies, and case-
control studies
IV Evidence from expert committee reports
or opinions or clinical experience of
respected authorities, or both
Recommendation grade
A Directly based on category I evidence
B Directly based on category II evidence or
extrapolated recommendation from
category I evidence
C Directly based on category III evidence or
extrapolated recommendation from
category I or II evidence
D Directly based on category IV evidence or
extrapolated recommendation from
category I, II, or III evidence
Voting on recommendation
A Accept completely
B Accept with some reservation
C Accept with major reservation
D Reject with reservation
E Reject completely
Adapted from Shekelle et al.2
International consensus recommendations for difﬁcult biliary access Liao et alto limit PEP risk. A cannulation attempt has been deﬁned as
an intentional continuous contact with the papilla.7 The
deﬁnition of difﬁcult cannulation varied widely among
previous studies; Table 2 summarizes prospective
randomized controlled trials (RCTs) that reported the
deﬁnition of difﬁcult cannulation and the number of
eligible patients and those with difﬁcult cannulation.8-19 A
prospective study showed that 97.4% of successful primary
cannulations were achieved within 5 attempts, and the risk
of PEP jumped from 6.1% to 11.9% with more attempts.7
The risk of PEP also signiﬁcantly increased when
cannulation time exceeded 10 minutes (odds ratio [OR],
1.76; 95% conﬁdence interval [CI], 1.13-2.74].20
Alternatively, situations such as gastric outlet obstruction
prevent access to the papilla and subsequent biliary
cannulation. The consensus panel deﬁned difﬁcult
cannulation as the inability to achieve selective biliary296 GASTROINTESTINAL ENDOSCOPY Volume 85, No. 2 : 2017cannulation by the standard ERCP technique within 10
minutes or 5 attempts or failureof access to themajor papilla.
The association between difﬁcult cannulation and higher
PEP risk supports tracking cannulation time/attempt and
rates of success and adverse events; it also underscores
the importance of achieving competence during ERCP
training and the issue of low-volume ERCP providers. An
80% success rate for biliary cannulation has been proposed
as the goal for ERCP training,21 and 1 study suggested that
350 to 400 supervised procedures are required to achieve
an 80% success rate in patients with native papilla.22 It is
reasonable to project that even more cases are needed to
achieve competence in advanced procedures to tackle
difﬁcult cannulation (eg, precut papillotomy, pancreatic
stent placement, EUS-guided biliary access, etc); future
research is needed to better deﬁne the minimum volume/
outcome requirements for these advanced procedures.
However, a survey in the United Sates found that graduating
fellows performed only a median of 140 ERCPs during
training and 64% of those fellows did not achieve the rec-
ommended competency, but 91% planned to perform un-
supervised ERCP after graduation.23 Low endoscopist
ERCP volume (<25 per year) has been shown to be
associated with a higher failure rate for ERCP and a
greater need for post-ERCP hospitalization.24 Further
efforts to tackle inadequate ERCP training and low
provider volume are needed to ensure ERCP quality/safety.
2. When endoscopic biliary access is difﬁcult, alternative
techniques may be required. These require speciﬁc exper-
tise and are potentially associated with a higher risk of
adverse events.
Evidence level: III
Recommendation grade: C
Voting on recommendation: A, 94%; B, 0%; C, 6%;
D, 0%; E, 0%
When encountering difﬁcult cannulation, one should
avoid persisting with the same technique to reduce the
risk of further injury to the papilla. One option is to repeat
the ERCP in the next 24 to 48 hours or refer to an expert
center.20 If a regular cannula is initially used, an
alternative method is to change to a sphincterotome or a
bendable-tip catheter.25,26 Other alternative methods
including DGW or precut technique, and EUS-guided or
percutaneous transhepatic biliary access may be applied
if the expertise is available. The use of these alternatives
may be associated with a higher risk of adverse events;
however, it is difﬁcult to determine whether the higher
risk is because of difﬁcult cannulation or of the alternative
procedures per se.15,27 These alternative methods are
further discussed in the following respective statements.
3. Prophylactic measures against PEP, such as rectal
nonsteroidal anti-inﬂammatory drugs and/or pancreatic
stent placement, are recommended when standard biliary
cannulation fails.www.giejournal.org
TABLE 2. Definition and incidence of difficult cannulation in RCTs
First author (year)
Definition of
difficult cannulation
No. of difficult cannulation/no. of
eligible subjects
Randomly assigned
intervention (n)
Maeda (2003)8 >10 min 53/107 (49.5%) DGW (27)
PC (26)
Tang (2005)9 >12 min (7 by trainee
and 5 by faculty)
62/642 (9.7%) NKP (32)
PC (30)
Zhou (2006)10 >10 min
>3 PD cannulation
91/948 (9.6%) NKP (43)
PC (48)
Cennamo (2009)11 >5 min
>3 PD cannulation
146/842 (17.3%) NKP (36)
PC (110)
Herreros de Tejada (2009)12 >5 attempts 188/845 (22.2%) DGW (97)
PC (91)
Manes (2009)13 >10 min
>5 PD injection
158/1654 (9.6%) Early NKF (80)
Late NKF (78)
Ito (2010)19 >5 attempts 108/1451 (7.4%) PD stent (35)
No stent (35)
Angsuwatcharakon (2012)14 >15 min (5 by
trainee 10 min by faculty)
44/426 (10.3%) DGW (23)
NKF (21)
Coté (2012)17 >6 min
>3 PD injection or cannulation
87/442 (19.7%) DGW (42)
PD stent (45)
Lee (2012)18 >10 min
>5 PD cannulation
>10 attempts
101/1522 (6.6%) PD stent (50)
No stent (51)
Swan (2013)15 >10 min*
>10 attempts*
>4 PD cannulation*
73/464 (15.7%) NKP (39)
PC (34)
Yoo (2013)16 >10 attempts
>10 min
71/1349 (5.2%) DGW (34)
TPS (37)
Zang (2014)42 >10 min
>5 PD cannulation
164/1181 (13.9%) TPS (73)
NKP (76)
Total 1346/11,873 (11.3%)
DGW, Double guidewire; PC, persistent standard cannulation; NKP, needle-knife papillotomy; PD, pancreatic duct; TPS, transpancreatic septotomy; NKF, needle-knife fistulotomy.
*By trainee and faculty: >5 minutes, >5 attempts, >2 PD cannulation, respectively.
Liao et al International consensus recommendations for difﬁcult biliary accessEvidence level: I-B
Recommendation grade: A
Voting on recommendation: A, 94%; B, 0%; C, 6%;
D, 0%; E, 0%
Difﬁcult cannulation is considered to be an independent
risk factor for PEP.20 A prospective study demonstrated
that PEP risk was signiﬁcantly higher when standard
cannulation failed (11.5%) compared with successful
cannulation (2.8%).7 Techniques such as precut and
DGW technique that are used after failed standard
cannulation may also increase PEP risk. The OR for the
precut technique from a recent meta-analysis was 2.30
(95% CI, 1.85-2.85),28 and the DGW technique appeared
to increase PEP risk in an RCT.16
A meta-analysis including 2133 patients from 7 RCTs
showed that rectal diclofenac or indomethacin reduced the
rates of overall PEP (relative risk, .44; 95% CI, .34-.57) and
of moderate-to-severe PEP (relative risk, .37; 95%
CI, .21-.63).29 Rectal nonsteroidal anti-inﬂammatory drugs
should be administered early when encountering difﬁcultwww.giejournal.orgcannulation, preferably before moving to alternative tech-
niques such as precut and DGWs. Temporary placement of
a pancreatic stent (3F or 5F) to facilitate pancreatic drainage
for 5 to 10 days has also been shown to reduce PEP risk20,30,31
and is recommended in patients at high risk of PEP.20 An RCT
in patients with difﬁcult cannulation found that pancreatic
stenting signiﬁcantly reduced the rate of PEP from 29.4% in
the no-stent group to 12% in the stented group (OR, .33;
95% CI, .12-.93).18 Pancreatic stenting also reduced PEP
after the DGW technique for difﬁcult cannulation in an
RCT; the rate of PEP was 23% in the no-stent group versus
2.9% in the stented group (relative risk, .13; 95%
CI, .02-.95).19 Leaving the stent for 7 to 10 days after precut
papillotomy over a pancreatic stent signiﬁcantly reduced
the risk and severity of PEP, compared with immediate
removal of the stent; the rates of PEP in stent-in-place and
stent-removed groups were 4.3% versus 21.3% (P < .05)
and those of moderate to severe PEP were 0% versus 12.8%
(P < .05), respectively.32 Whether rectal nonsteroidal anti-
inﬂammatory drugs can obviate the need for pancreaticVolume 85, No. 2 : 2017 GASTROINTESTINAL ENDOSCOPY 297
International consensus recommendations for difﬁcult biliary access Liao et alstenting in patients at high risk of PEP is not clear and war-
rants further study.
4. Precut or pancreatic guidewire-assisted techniques
are appropriate when biliary cannulation is difﬁcult.
Evidence level: I-B
Recommendation grade: A
Voting on recommendation: A, 94%; B, 6%; C, 0%;
D, 0%; E, 0%
When repeated standard cannulation attempts fail to
access the bile and pancreatic duct, the precut technique
involves derooﬁng the ampullary mucosa to expose the
biliary lumen and is the preferred next-line method.1 A
meta-analysis showed that precut technique had a higher
success rate but similar PEP rate compared with persistent
cannulation attempts.33 The rates of success and PEP for
precut technique and persistent cannulation were 86.7%
versus 66.7% (relative risk, 1.32; 95% CI, 1.04-1.68) and
6.1% versus 9.1% (relative risk, .62; 95% CI, .28-1.36),
respectively.33 Another meta-analysis showed that the
ORs of PEP for using the precut technique immediately
and within 5 or 10 minutes of standard cannulation were
.73 (95% CI, .23-2.33), .85 (95% CI, .40-1.80), and .55
(95% CI, .29-1.03), respectively.34 In terms of PEP, 10
minutes appears to be the optimum time allowed for the
standard cannulation technique before considering the
use of precut technique. Notably, precut technique
requires expertise and is associated with a higher risk of
adverse events, particularly perforation and bleeding,
when performed by low-volume endoscopists.35 Previous
studies suggested that 200 and 100 precuts are required
to achieve high success and low bleeding rates,
respectively.27,36
If the guidewire inadvertently enters the pancreatic
duct during standard biliary cannulation, the DGW tech-
nique or cannulation over a pancreatic duct stent can be
used as the next-line modality before precut technique.
The DGW technique is performed by placing the ﬁrst
guidewire in the pancreatic duct followed by selective
biliary cannulation with a second guidewire. The ﬁrst
guidewire not only acts as a landmark but also facilitates
cannulation by straightening the duodenal portion of the
common channel. Three RCTs evaluated the DGW tech-
nique in difﬁcult cannulation.12,14,16 The pooled success
rate of the DGW technique was 58% (range, 47%-
79%)8,12,14,16; the success rate was comparable with precut
technique16,36 and was similar to attempts at persistent
cannulation.12 The pooled PEP rate of the DGW
technique was 22% (range, 17%-38%)12,14,16; the rate of
PEP was comparable with that of persistent cannulation8,12
or precut using the ﬁstulotomy technique14 but was higher
than that of precut using the transpancreatic technique.16
A complementary technique to DGW with comparable
efﬁcacy and safety is to place a pancreatic stent after
inadvertent access to the pancreatic duct, followed by
biliary cannulation over the stent.17 If the DGW298 GASTROINTESTINAL ENDOSCOPY Volume 85, No. 2 : 2017technique or cannulation over a pancreatic duct stent
still fails to achieve biliary access, precut over the
pancreatic stent or transpancreatic septotomy (TPS) can
be used as the next-line modality.
5. All precut techniques achieve a high biliary access
rate. Needle-knife ﬁstulotomy (NKF) may be associated
with fewer adverse events.
Evidence level: I-B
Recommendation grade: A
Voting on recommendation: A, 56%; B, 38%; C, 6%;
D, 0%; E, 0%
Precut techniques include needle-knife papillotomy
(NKP),37 NKF,38 and TPS.39 NKP starts cutting from the
papillary oriﬁce toward the 11 o’clock direction.37 In
contrast, NKF38 starts at 3 to 5 mm above the papillary
oriﬁce in the same direction as NKP; therefore, NKF may
be easier to perform when the intraduodenal segment of
the bile duct is long or prominent. In TPS, after
superﬁcial or deep cannulation of the pancreatic duct is
achieved, a sphincterotome is inserted into the
pancreatic duct and cuts the septum between bile and
pancreatic ducts toward the 11 o’clock direction.39
For NKF, NKP, and TPS the initial success rates were
75.7% to 100%, 73.4% to 84.2%, and 95.8% to 100%,
respectively38,40-42 (Table 3). An RCT demonstrated
comparable success rates between NKF and NKP after
failed standard cannulation; the primary success rates
were 75.7% and 73.4%, and the cumulative success rates
after repeat cannulation at 48 to 72 hours were 90.5%
and 88.6%, respectively.38 Two RCTs showed that TPS
had higher primary success rates than NKP (100% vs
77%, P Z .01,43 and 95.9% vs 84.2%, P Z .018,42
respectively).
Unlike NKP and TPS, NKF does not involve the pancre-
atic oriﬁce. An RCT demonstrated that NKF had a lower
risk of PEP than NKP (0% vs 7.6%, P < .05).38 Subgroup
analysis of a meta-analysis revealed that NKF signiﬁcantly
decreased the risk of PEP (OR, .27; 95% CI, .09-.82) with
an absolute risk reduction of 5% (95% CI, 1%-10%),
whereas NKP did not (OR, .89; 95% CI, .41-1.92).34 In
a retrospective study NKF had a lower PEP rate than the
others; the PEP rates of NKF, NKP, and TPS were 2.6%,
21%, and 22.4%, respectively (P Z .001).40 Therefore, if
the pancreatic duct can be cannulated, a pancreatic stent
should be placed before NKP to guide the precut and to
reduce PEP risk; a retrospective study showed that
precutting over a pancreatic stent achieved a higher
success rate and a lower adverse event rate.20,44 The stent
should be left in place after ERCP; in an RCT the risk of PEP
with stent in place versus stent removal after precut over
the stent was 4.3% versus 21.3% (P Z .027).32 It is also
reasonable to leave a pancreatic stent after TPS for
prophylaxis of PEP.20 There was no signiﬁcant difference
in the rates of bleeding and perforation among the
3 techniques (Table 3).38,40-42www.giejournal.org
TABLE 3. Success and adverse event rates of the 3 precut techniques in patients with failed standard cannulation
First author (year) Study design Technique
Initial
success (%)
Success after
second attempt (%) Pancreatitis (%) Bleeding (%) Perforation (%)
Katsinelos (2012)40 Retrospective NKF
NKP
TPS
92.3
83.7
100
(NS)
98.7
97.7
NA
(NS)
2.6
21
22.4
(P < .05)
5.2
3.9
0
(NS)
0
.8
0
(NS)
Horiuchi (2007)41 Retrospective NKF
NKP
TPS
100
90
95.8
(NS)
NA
100
100
0
3.3
2.1
(NS)
0
6.7
0
(NS)
0
0
0
(NS)
Mavrogiannis (1999)38 RCT NKF
NKP
75.7
73.4
(NS)
90.5
88.6
(NS)
0
7.6
(P < .05)
6.8
5.1
(NS)
2.7
2.5
(NS)
Catalano (2004)43 RCT NKP
TPS
75
94
(NS)
NA
NA
12.5
3.2
(NS)
6.3
0
(NS)
0
0
Zang (2014)42 RCT NKP
TPS
84.2
95.9
(P < .05)
NA
NA
6.6
6.8
(NS)
3.9
1.4
(NS)
0
0
(NS)
NKP, Needle-knife papillotomy; NKF, needle-knife fistulotomy; TPS, transpancreatic septotomy; NA, not available; NS, not significant; RCT, randomized controlled trial.
Liao et al International consensus recommendations for difﬁcult biliary accessCollectively, all precut techniques performed in
the setting of difﬁcult cannulation had success rates of
70% to 90% with similar bleeding and perforation
rates. NKF had lower PEP rates than other precut
techniques.
6. In patients with Billroth II anatomy, both side-viewing
and conventional forward-viewing endoscopes may
achieve comparable biliary access. The use of side-
viewing endoscopes may be associated with a higher risk
of perforation.
Evidence level: I-B
Recommendation grade: A
Voting on recommendation: A, 62.5%; B, 37.5%; C, 0%;
D, 0%; E, 0%
In Billroth II anatomy, the papilla can be accessed by
either side-viewing or forward-viewing endoscopes
because the afferent limb is relatively short. The main
challenge is duodenal intubation with side-viewing duo-
denoscopes and cannulation without an elevator with
forward-viewing endoscopes. A longitudinal case series
that included 713 patients with Billroth II anatomy under-
going ERCP showed that the success rates of duodenal
intubation with side-viewing endoscopes was 84%, with
an overall perforation rate of 1.8%.45 The overall failure
rate decreased from 54% in the ﬁrst 5 years to 12% to
22% in the subsequent 25 years.45 A small RCT
comparing side-viewing and forward-viewing endoscopes
in 45 patients with Billroth II anatomy showed no
signiﬁcant difference in the overall success rate (68%
and 87%, respectively).46 The main reasons for failure
with side-viewing endoscopes were jejunal perforation
(18%), failure to reach the papilla (9%), and severewww.giejournal.orgabdominal pain (4.5%). Once the papilla could be
reached, side-viewing endoscopes achieved cannulation
in all patients. This study raises concerns about using
side-viewing endoscopes because it carried a higher risk
of jejunal perforation compared with forward-viewing
endoscopes (18% vs 0%, P < .05).46 However, the rate
of jejunal perforation in this study was higher than
those of other reports (.7%-10.2%).45,47 The higher perfo-
ration risk might be attributed to the longer tip of the
earlier duodenoscopes, and this risk may have become
lower with the evolution of endoscope design.45 In
addition, device-assisted enteroscopy using short
single-balloon or double-balloon enteroscopes can
also be used in Billroth II anatomy with a high
success rate.48
7. In surgically altered anatomy, particularly Roux-en-Y
anastomosis, device-assisted enteroscopy may facilitate
access to the papilla or bilioenteric anastomosis.
Evidence level: I-A
Recommendation grade: A
Voting on recommendation: A, 81%; B, 19%; C, 0%;
D, 0%; E, 0%
Compared with Billroth II anatomy, Whipple procedure
or Roux-en-Y anastomosis poses greater challenges in
endoscope intubation and biliary cannulation.49,50 Identi-
fying the afferent limb and reaching the biliary oriﬁce can
be challenging and potentially complicated by mucosal
tears or even perforation. Unfavorable angles may render
cannulation difﬁcult.
Device-assisted enteroscopy represents a breakthrough
in biliary access for patients with surgically altered anat-
omy. Shah et al51 reported a large multicenter U.S. seriesVolume 85, No. 2 : 2017 GASTROINTESTINAL ENDOSCOPY 299
TABLE 4. Comparison of transgastric and transduodenal routes for EUS-guided biliary access
First author (year)
Design Patient number
(transgastric/transduodenal)
Transgastric vs transduodenal
Success
n
Adverse events
n
Dhir (2013)78 Retrospective 17/18 16 (94.1%) vs 18 (100%) Bile leak: 2 (11.7%) vs 0
Pneumoperitoneum:
2 (11.7%) vs 0
Dhir (2014)61 Retrospective 36/32 34 (94.4%) vs 31 (96.8%) 11 (30.5%) vs 3 (9.3%)*
Kawakubo (2014)59 Retrospective 20/44 19 (95%) vs 42 (95%) 6 (30%) vs 6 (14%)
Poincloux (2015)66 Retrospective 71/30 66 (94.3%) vs 27 (93.1%) 10 (14.1%) vs 2 (6.7%)
Artifon (2015)62 Prospective 25/24 22 (91%) vs 17 (77%) 5 (20%) vs 3 (12.5%)
*P < .05.
International consensus recommendations for difﬁcult biliary access Liao et alusing single-balloon, double-balloon, and rotational
overtube-assisted enteroscopy for ERCP in patients with
surgically altered anatomy. The largest patient subsets
were post Roux-en-Y gastric bypass and Whipple proced-
ure (intact papilla) followed by nontransplant Roux-en-Y
hepaticojejunostomy. Overall, ERCP was successful in
63% of patients. The success rate increased to 88% when
the biliary oriﬁce was reached. Enteroscopy success was
comparable among the 3 techniques.51 In a more recent
series, double-balloon enteroscopy-assisted ERCP was suc-
cessful in 95% of patients with prior Roux-en-Y.52 Studies
involving single-balloon endoscopy ERCP in patients with
Roux-en-Y gastric bypass, hepaticojejunostomy, or Whipple
procedure (15 trials, 461 patients) were assessed in a
recent meta-analysis. Overall, enteroscopy success was
80.9% and procedural success was 61.7%, with adverse
events occurring in 6.5% of patients.53
Besides device-assisted enteroscopy, direct puncture
into bile duct under EUS guidance provides biliary access
without the need to access the papilla or bilioenteric anas-
tomosis (see statement 8, below). Alternatively, ERCP can
be performed in an antegrade fashion through a transcuta-
neous gastrostomy into the remnant stomach using a duo-
denoscope. Gastrostomy can be created either by
laparoscopy (laparoscopy-assisted ERCP)54 or by ﬁrst
using EUS to puncture and insufﬂate the remnant
stomach followed by direct percutaneous puncture.55,56
Case series showed a success rate exceeding 90% with
this approach,54-56 providing support for transgastric
ERCP as a valuable addition to biliary endoscopists’ arma-
mentarium for managing patients with surgically altered
anatomy.
8. EUS-guided biliary access is a viable method for
drainage of an obstructed system when cannulation via
the papilla is unsuccessful by conventional methods or if
the papilla is not accessible.
Evidence level: I-A
Recommendation grade: A
Voting on recommendation: A, 81%; B, 19%; C, 0%;
D, 0%; E, 0%300 GASTROINTESTINAL ENDOSCOPY Volume 85, No. 2 : 2017EUS-guided biliary access has emerged as a viable alter-
native when ERCP fails. After EUS-guided puncture of intra-
hepatic or extrahepatic bile ducts from the stomach or
duodenum, subsequent biliary therapy can be performed
either by transluminal or antegrade approaches or by the
rendezvous technique. As the access site is removed
from the papilla, this technique can be applied in patients
with duodenal stenosis or surgically altered anatomy. Two
recent meta-analyses showed that EUS-guided biliary
drainage (EUS-BD) can achieve success rates of 90% with
adverse event rates around 20%.57,58
9. Where both EUS-guided biliary access routes are
possible, the transduodenal approach, when appropriate,
appears to be safer than transgastric access.
Evidence level: II-B
Recommendation grade: B
Voting on recommendation: A, 81%; B, 19%; C, 0%;
D, 0%; E, 0%
Transgastric and transduodenal routes can be used for
EUS-guided biliary access.59,60 The success and adverse
event rates of the 2 access routes are summarized in
Table 4. A review comparing these 2 access routes in
published studies with 25 or more cases, including 211
transduodenal and 138 transhepatic cases, found that the
adverse event rate was higher with the transhepatic route
(21.7% vs 9.9%, P  .01).61 A recent RCT that compared
EUS-guided hepaticogastrostomy (EUS-HGS) and EUS-
guided choledochoduodenostomy in patients with
malignant distal biliary obstruction found that the 2
approaches were comparable in terms of technical success
(96% vs 91%, respectively, PZ .609), quality of life scores,
and survival (PZ .603). EUS-HGS seemed to have a higher
clinical success rate (91% vs 77%, PZ .234) and a higher im-
mediate adverse event rate (20% vs 12.5%, PZ .702) than
EUS-guided choledochoduodenostomy, but the
differences were not statistically signiﬁcant.62 A recent
meta-analysis showed that the transduodenal route was
safer than the transgastric route (pooled OR for adverse
events, .4; 95% CI, .18-.87).58 In another meta-analysis, the
pooled OR for adverse events for the transduodenal versuswww.giejournal.org
TABLE 5. Choice of endoscopes and access routes in various scenarios
of difficult biliary access
Difficult
cannulation
in normal
anatomy
Billroth II
anatomy
Roux-en-Y
anastomosis
Duodenoscope Yes Yes No
Forward-viewing
upper endoscope
No Yes No
Device-assisted
enteroscope
No Yes (in a long
afferent limb)
Yes
EUS-BD Yes Yes Yes
Percutaneous
biliary drainage
Yes Yes Yes
EUS-BD, EUS-guided biliary drainage.
Liao et al International consensus recommendations for difﬁcult biliary accesstransgastric route was .61 (95% CI, .36-1.03).57 The higher
adverse event rate of HGS, most notably bile leak, may be
attributed to the longer distance between the puncture
site and the bile duct through liver parenchyma.
Furthermore, the stent is placed in the common bile duct
with choledochoduodenostomy but in the intrahepatic
bile duct with HGS; segmental cholangitis from
obstruction of side branches may occur with HGS.63
10. EUS-BD may be performed with high success
and an acceptable adverse event rate, in experienced
hands.
Evidence level: I-A
Recommendation grade: A
Voting on recommendation: A, 77%; B, 23%; C, 0%;
D, 0%; E, 0%
A retrospective analysis comparing ERCP and EUS-BD
after failed ERCP for biliary drainage in cases of malignant
distal biliary obstruction found that the 2 approaches were
comparable with respect to success of stent placement
(94.23% vs 93.26%), adverse events (8.65% vs 8.65%),
and procedure time.64 The risk of pancreatitis appeared
to be lower with EUS-BD compared with ERCP (0% vs
4.8%, P Z .059).64 Although case series of EUS-BD per-
formed by experienced endoscopists suggested EUS-BD
is comparable with ERCP in terms of short-term outcomes,
EUS-BD is less successful and more risky when performed
by inexperienced endoscopists. A Spanish national survey
on EUS-BD conducted in hospitals with an experience of
fewer than 20 procedures showed that EUS-BD was techni-
cally successful in only 68.9% of 73 patients with an adverse
event rate of 22.6%.65 Another single-center retrospective
study also observed a higher adverse event rate among
the ﬁrst 50 cases.66 Taken together, EUS-BD is still rela-
tively nascent and should only be performed by expert en-
doscopists experienced in this procedure. In experienced
hands, EUS-BD is a safe and effective salvage procedure
for endoscopic biliary drainage when transpapillary biliary
access has failed or is impossible.59,60,67www.giejournal.org11. Percutaneous transhepatic access is a viable method
of biliary intervention when endoscopic methods fail or are
not appropriate.
Evidence level: I-B
Recommendation grade: A
Voting on recommendation: A, 81%; B, 13%; C, 6%;
D, 0%; E, 0%
In patients with a dilated biliary tract from biliary
obstruction, percutaneous transhepatic puncture of the
bile duct is widely used to achieve biliary access when
ERCP fails.68 After biliary access is achieved, drainage can
be performed by placing an external catheter or an
internal stent or by passing a guidewire into the
duodenum for subsequent rendezvous procedure using a
duodenoscope or an enteroscope where applicable.
The technical success rate of this method approaches
100% in cases with dilated bile ducts and is expected to
exceed 70% with nondilated bile ducts.69 Although mild
bleeding after transhepatic puncture is common and
usually self-limiting, severe bleeding may occur. In a
nationwide audit in Japan, the rate of severe bleeding
requiring transfusion and/or arterial embolization after
percutaneous transhepatic biliary drainage (PTBD) was
2.3% among 34,606 cases.70
12. Percutaneous transhepatic and EUS-guided biliary
access appear to be comparable in terms of efﬁcacy and
may be appropriate in surgically altered anatomy.
Evidence level: I-B
Recommendation grade: A
Voting on recommendation: A, 56%; B, 31%; C, 13%;
D, 0%; E, 0%
A retrospective study comparing EUS-BD and PTBD in
patients with distal biliary obstruction and failed ERCP
found that the clinical success rates were comparable
(86.4% vs 92.2%, P Z 0.4), but PTBD had a higher rate
of adverse events during the index and reintervention pro-
cedures compared with EUS-BD (70.6% vs 18.2%,
P < .001).71 In an RCT comparing PTBD (n Z 12) and
EUS-BD (n Z 13) in patients with malignant biliary
obstruction and failed ERCP, technical and clinical success
were achieved in all patients without signiﬁcant differences
in the adverse event rate and cost.72 However, given the
limited sample size, the study may not have been
adequately powered to show a difference. A recent RCT
evaluating patients with malignant distal biliary
obstruction and inaccessible papilla also found that PTBD
(n Z 32) and EUS-BD (n Z 34) had comparable rates of
technical (96.9% vs 94.1%) and functional success
(87.1% vs 87.5%), but patients undergoing EUS-BD had
fewer adverse events (8.8% vs 31.2%, P Z .022) and rein-
terventions (25% vs 54.8%, P Z .015).73 However, it
should be cautioned that those studies were conducted
in referral centers by expert endoscopists experienced in
EUS-BD, and thus the results may not be directly generaliz-
able to other settings. It is important to consider availabilityVolume 85, No. 2 : 2017 GASTROINTESTINAL ENDOSCOPY 301
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EUS-guided access. Collectively, EUS-guided and percuta-
neous transhepatic biliary access have comparable tech-
nical and functional success rates; EUS-guided access may
carry a lower adverse event rate in experienced hands.
The possible choices of endoscopes and access routes
for biliary access in various scenarios of difﬁcult biliary ac-
cess are summarized in Table 5.
13. In the presence of signiﬁcant duodenal stenosis,
endoscopic balloon dilation and/or enteral stenting fol-
lowed by standard biliary cannulation may be considered.
EUS-guided or percutaneous biliary access techniques are
alternative ﬁrst-line approaches.
Evidence level: III
Recommendation grade: C
Voting on recommendation: A, 75%; B, 19%; C, 6%;
D, 0%; E, 0%
When the papilla is not accessible because of duodenal
stenosis, balloon dilation of the stenosis and/or duodenal
stenting may enable passage of a duodenoscope and subse-
quent biliary access. The success rate of dilation varied from
0 to 87% in previous studies.74-76 Identifying the papilla can
be challenging because of postdilation bleeding.74 Dilation
also carries a risk of perforation; 1 study reported
perforation in 1 of 16 patients after dilation of duodenal
stenosis for access to the papilla.76 If dilation alone is
insufﬁcient, further placement of a self-expanding metal
stent (SEMS) may allow passage of the duodenoscope.74,76
Mutignani et al reported74 that duodenoscope passage
through the duodenal SEMS was successful in 63 of 64
patients without stent displacement after biliary drainage.
Placement of a SEMS also palliates symptomatic
obstruction from duodenal stenosis.75
EUS-guided and percutaneous transhepatic biliary
access are alternative approaches in cases with signiﬁcant
duodenal stenosis. Both approaches directly puncture
the bile duct, obviating the need to access the papilla. A
multicenter retrospective study suggested that in patients
with prior duodenal SEMS placement and biliary obstruc-
tion, biliary SEMS insertion via EUS-BD may be associated
with a longer stent patency compared with the transpapil-
lary route, likely because of food impaction in the
duodenal SEMS.77 Although no prospective study has
compared biliary access after dilation of duodenal
stricture with or without stenting versus EUS-guided or
percutaneous transhepatic biliary access, the latter might
be preferable if the duodenal stenosis does not cause
signiﬁcant obstruction requiring palliation.REFERENCES
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